Literature DB >> 25870080

Charles Bonnet Syndrome in Advanced Retinitis Pigmentosa.

Fleur O'Hare1, Sharon A Bentley2, Zhichao Wu1, Robyn H Guymer1, Chi D Luu1, Lauren N Ayton3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25870080     DOI: 10.1016/j.ophtha.2015.03.006

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  7 in total

Review 1.  The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.

Authors:  Ali G Hamedani; Victoria S Pelak
Journal:  Curr Treat Options Neurol       Date:  2019-07-25       Impact factor: 3.598

2.  Charles Bonnet's syndrome: not only a condition of the elderly.

Authors:  Heike M Elflein; M Rudy; K Lorenz; K A Ponto; A Scheurich; S Pitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-25       Impact factor: 3.117

3.  Reorganization of early visual cortex functional connectivity following selective peripheral and central visual loss.

Authors:  Norman Sabbah; Nicolae Sanda; Colas N Authié; Saddek Mohand-Saïd; José-Alain Sahel; Christophe Habas; Amir Amedi; Avinoam B Safran
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

4.  Charles Bonnet Syndrome in a Patient with Parkinson's Disease and Bilateral Posterior Capsule Opacification.

Authors:  Amenze Angel Osa; Trent J Bowen; Jess T Whitson
Journal:  Int Med Case Rep J       Date:  2020-01-10

Review 5.  Light, sleep-wake rhythm, and behavioural and psychological symptoms of dementia in care home patients: Revisiting the sundowning syndrome.

Authors:  Ta-Wei Guu; Dag Aarsland; Dominic Ffytche
Journal:  Int J Geriatr Psychiatry       Date:  2022-05       Impact factor: 3.850

6.  Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs.

Authors:  Nancy Cross; Cécile van Steen; Yasmina Zegaoui; Andrew Satherley; Luigi Angelillo
Journal:  Clin Ophthalmol       Date:  2022-06-20

Review 7.  Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome.

Authors:  Linda Pang
Journal:  Optom Vis Sci       Date:  2016-12       Impact factor: 1.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.